Eli Lilly & Co. (LLY) Announces Publication of Positive Taltz Phase 3 Data in Moderate-to-Severe Plaque Psoriasis
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) announced that the New England Journal of Medicine has published detailed results from three ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
